Browsing: Reform

Guest Op-Ed by Gretchen Gailey, President of Project Champion If there is one lesson the cannabis industry should have learned by now, it’s this: Washington does…

President Donald Trump publicly acknowledged on Monday that his administration is actively considering reclassifying cannabis under federal law, saying the current Schedule I status blocks medical…

Trump is reportedly weighing a directive that would push federal agencies to move cannabis from Schedule I to Schedule III, but the White House says no…

“The only clearly understood consequence of moving cannabis to Schedule III is ending the unfair, excessive tax burden, providing a financial benefit for all marijuana companies…

After months of silence and bureaucratic stalling, the DEA finally has a new boss: Terrance Cole, confirmed by the Senate earlier this week. That might not…

Twenty-six companies spent over $1.6 million on lobbying in Pennsylvania for cannabis reforms last year, according to a Spotlight PA analysis, with over $800,000 coming from…

As the U.S. cannabis community awaits the resumption of the DEA’s administrative law hearing on rescheduling marijuana later this month, this blog will take a glimpse…

Earlier this year, the DEA initiated rulemaking to reclassify cannabis as a schedule III narcotic. This is probably the biggest news in cannabis reform since the…

The Japanese government announced on May 30 that it would officially begin accepting public comments about its cannabis reform bill. One of the proposed measures would…

When Joseph R. Biden delivered the State of the Union address in March, he became the first United States president to use the word “marijuana” in…